![Christopher Tapper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Tapper
Direttore/Membro del Consiglio presso
Microbiotica Ltd.
Profilo
Christopher Tapper currently works at Microbiotica Ltd., as Director from 2020, Exvastat Ltd., as Director from 2020, and Cambridge Innovation Capital Ltd, as Principal.
Mr. Tapper received his undergraduate degree in 2014 from the University of Cambridge.
Posizioni attive di Christopher Tapper
| Società | Posizione | Inizio |
|---|---|---|
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Investitore di Private Equity | - |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Direttore/Membro del Consiglio | 01/08/2020 |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Direttore/Membro del Consiglio | 01/09/2020 |
Formazione di Christopher Tapper
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
40
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Finance |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Health Technology |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Health Technology |
